Michael Lawton, MD, is the President and CEO of Barrow Neurological Institute and the Chair of the Department of Neurosurgery. He is board certified by the American Board of Neurological Surgery.

Dr. Lawton’s neurosurgical expertise includes cerebrovascular disorders (aneurysms, arteriovenous malformations, cavernous malformations, and stroke) and skull base tumors. He has experience in treating more than 4,000 brain aneurysms, 800 AVMs, and 1,000 cavernous malformations. He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, Society of Neurological Surgeons, American Academy of Neurological Surgery, and World Academy of Neurological Surgery.

Dr. Lawton received a degree in biomedical engineering from Brown University and his medical degree from Johns Hopkins University School of Medicine. He completed his neurosurgery residency at Barrow, where he also completed a fellowship in cerebrovascular and skull base surgery. After joining the faculty at University of California, San Francisco, he later completed a fellowship in endovascular surgery there.

Dr. Lawton’s research studies the formation, underlying genetics, and rupture of brain AVMs, as well as the hemodynamics, rupture, and computational modeling of brain aneurysms. His clinical research studies the anatomy of microsurgical approaches and clinical outcomes of microsurgery for aneurysms, AVMs, and bypass surgery. He is the principal investigator for the Brain Vascular Malformation Consortium, a NIH-funded multicenter group studying the genetics and clinical course of rare vascular diseases of the brain. He has published over 450 peer-reviewed articles, three single-author textbooks, and over 70 book chapters. He co-founded Mission:BRAIN, a teaching mission to raise the level of neurosurgery practiced in developing countries that conducts annual missions in Mexico and Asia.